Latest Share Chat

AKR.L Regulatory News (AKR)

AKR.L Information

There is currently no data for AKR

Change of Adviser

19 Mar 2010 13:00

RNS Number : 8648I

Akers Biosciences, Inc.

19 March 2010

For immediate release: 19 March 2010

Akers Biosciences, Inc.

(the "Company")

Change of Adviser

Akers Biosciences, Inc (AIM:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, is pleased to announce the appointment of Daniel Stewart & Company plc as Nominated Adviser and Broker to the Company with immediate effect.

Enquiries:

Thomas A. Nicolette

President and CEO

Tel. +1 856 848 8698

Ben Simons

M: Communications

Tel. +44 (0)20 7920 2340

Emma Earl or Simon Leathers

Daniel Stewart & Co.

Tel. +44 (0)20 7776 6550

This information is provided by RNS

The company news service from the London Stock Exchange

END

APPLLFELVIIALII

Date		Source	Headline
8th May 2018	1:00 pm	RNS	Holding(s) in Company
27th Apr 2018	2:05 pm	RNS	Second Price Monitoring Extn
27th Apr 2018	2:00 pm	RNS	Price Monitoring Extension
26th Apr 2018	7:00 am	RNS	Directorate Change
13th Apr 2018	5:45 pm	RNS	Issue of Equity
12th Apr 2018	12:00 pm	RNS	Independent Sales Representative Agreements - PIFA
6th Apr 2018	4:30 pm	RNS	Issue of Equity
3rd Apr 2018	11:05 am	RNS	Final Results
28th Mar 2018	4:20 pm	RNS	Notice of Fiscal Year 2017 Earnings - Rescheduled
26th Mar 2018	7:01 am	RNS	Distribution Agreement with Diagnostica Stago
26th Mar 2018	7:00 am	RNS	Issue of Equity
16th Mar 2018	4:00 pm	RNS	Issue of Equity
15th Mar 2018	5:30 pm	RNS	Notice of Results
9th Mar 2018	6:29 pm	RNS	Issue of Equity
2nd Mar 2018	5:15 pm	RNS	Issue of Equity
16th Feb 2018	5:45 pm	RNS	Issue of Equity
14th Feb 2018	5:30 pm	RNS	Holdings in Company
9th Feb 2018	6:00 pm	RNS	Issue of Equity
2nd Feb 2018	4:42 pm	RNS	Issue of Equity
26th Jan 2018	7:00 am	RNS	Issue of Equity
22nd Jan 2018	4:27 pm	RNS	Holdings in Company
19th Jan 2018	3:35 pm	RNS	Issue of Equity
16th Jan 2018	6:20 pm	RNS	Issue of Equity
15th Jan 2018	7:00 am	RNS	Update RE Admission of Shares
12th Jan 2018	7:00 am	RNS	Issue of Equity
5th Jan 2018	6:29 pm	RNS	Issue of Equity
4th Jan 2018	4:45 pm	RNS	Holdings in Company
27th Dec 2017	2:01 pm	RNS	Issue of Equity
22nd Dec 2017	7:00 am	RNS	Closing of Public Offering
19th Dec 2017	7:00 am	RNS	Issue of Equity
18th Dec 2017	11:00 am	RNS	Form S-1 Registration Statement - Amendment
15th Dec 2017	11:00 am	RNS	Form S-1 Registration Statement - Amendment
14th Dec 2017	11:00 am	RNS	Form S-1 Registration Statement - Amendment
11th Dec 2017	11:00 am	RNS	Form S-1 Registration Statement - Amendment
8th Dec 2017	3:30 pm	RNS	Further IP Protection for Akers Wellness Line
1st Dec 2017	2:00 pm	RNS	Form 8K Filing
27th Nov 2017	7:00 am	RNS	Form S-1 Registration Statement
15th Nov 2017	7:00 am	RNS	3rd Quarter Results
14th Nov 2017	7:00 am	RNS	New UK Channel for Rapid Alcohol Breathalyzer
13th Nov 2017	2:00 pm	RNS	Notice of Results
8th Nov 2017	1:59 pm	RNS	Issue of Equity
20th Oct 2017	7:00 am	RNS	PDMR Shareholding and Issue of Equity
19th Oct 2017	4:20 pm	RNS	Director/PDMR Shareholding
13th Oct 2017	2:35 pm	RNS	Warrant Amendment and Exercise
7th Sep 2017	7:00 am	RNS	Appointment of U.S. VP of Sales & Distribution
15th Aug 2017	7:00 am	RNS	Half-year Report
11th Aug 2017	7:00 am	RNS	Issue of Equity
8th Aug 2017	7:00 am	RNS	Result of AGM
3rd Aug 2017	4:30 pm	RNS	Trading Update and Notice of Q2 Results
20th Jul 2017	11:10 am	RNS	Holding(s) in Company

Latest Share Chat

AKR.L Regulatory News (AKR)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of Adviser

Login to your account

Quickpicks are a member only feature

Login to your account